[1] |
中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1):38-44.
|
|
Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association;Severe Liver Disease and Artificial Liver Group,Chinese Society of Hepatology,Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1):38-44.
|
[2] |
尚大宝, 项晓刚. 慢加急性肝衰竭的发病机制和治疗进展[J]. 临床肝胆病杂志, 2021, 37(4):765-769.
|
|
Shang DB, Xiang XG. Advances in the pathogenesis and treat-ment of acute-on-chronic liver failure[J]. J Clin Hepatol, 2021, 37(4):765-769.
|
[3] |
Choudhary NS, Saraf N, Saigal S, et al. Letter to the editor:incidence and mortality of acute on chronic liver failure using two definitions in patients with compensated cirrhosis[J]. Hepatology, 2019, 70(6):2235-2236.
DOI
PMID
|
[4] |
吴凤萍, 李亚萍, 杨颖, 等. 血糖和总胆固醇水平对肝衰竭患者预后的影响[J]. 实用肝脏病杂志, 2018, 21(3):413-416.
|
|
Wu FP, Li YP, Yang Y, et al. Blood glucose and total cholesterol in the prognosis of patients with liver failure[J]. J Pract Hepatol, 2018, 21(3):413-416.
|
[5] |
胡欣欣. HBV相关慢加急性肝衰竭患者血糖变化及其危险因素分析[D]. 遵义:遵义医科大学, 2018.
|
|
Hu XX. Analysis of blood glucose changes and risk factors in patients with HBV related acute-on-chronic liver failure[D]. Zunyi:Zunyi Medcial University, 2018.
|
[6] |
孔金峰, 林太顺, 陈丽芳, 等. 血总胆固醇、血糖及MELD评分对乙型肝炎相关慢加急性肝衰竭近期预后的评估[J]. 中国医药指南, 2021, 19(25):18-19.
|
|
Kong JF, Lin TS, Chen LF, et al. Assessment of short-term prognosis of hepatitis B related chronic acute liver failure by total cholesterol,blood glucose and MELD score[J]. Guid China Med, 2021, 19(25):18-19.
|
[7] |
张帆. 血糖、胆固醇水平与肝衰竭患者预后的相关性分析[J]. 临床医学, 2021, 41(3):24-26.
|
|
Zhang F. Correlation of levels of blood glucose and cholesterol with prognosis of patients with liver failure[J]. Clin Med, 2021, 41(3):24-26.
|
[8] |
孙振球. 医学统计学[M]. 2版. 北京: 人民卫生出版社, 2007.
|
|
Sun ZQ. Medical statistics[M]. 2nd ed. Beijing: People’s Medical Publishing House, 2007.
|
[9] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4):315-409.
|
|
Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Chin J Diabetes Mellitus, 2021, 13(4):315-409.
|
[10] |
徐小元, 丁惠国, 李文刚, 等. 肝硬化诊治指南[J]. 实用肝脏病杂志, 2019, 22(6):770-786.
|
|
Xu XY, Ding HG, Li WG, et al. Guidelines for the diagnosis and treatment of liver cirrhosis[J]. J Pract Hepatol, 2019, 22(6):770-786.
|
[11] |
刘玲, 岳彩霞. Child-Pugh分级联合血清PA、CHE、PTA水平在肝硬化患者病情评估中的应用价值[J]. 中国民康医学, 2019, 31(13):114-115.
|
|
Liu L, Yue CX. Application value of Child-Pugh classification combined with serum PA,CHE and PTA levels in the evaluation of patients with liver cirrhosis[J]. Med J Chin People’s Heal, 2019, 31(13):114-115.
|
[12] |
Kamath PS, Kim WR. Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD)[J]. Hepatology, 2007, 45(3):797-805.
DOI
URL
|
[13] |
陈永泰, 柯瑞盛, 蔡秋程, 等. 终末期肝病模型及MELD-Na评分在肝移植应用中的研究进展[J]. 中华普通外科学文献(电子版), 2019, 13(6):488-491.
|
|
Chen YT, Ke RS, Cai QC, et al. Advances in the application of model for end-stage liver disease and MELD-Na scores in liver transplantation[J]. Chin Arch Gen Surg Electron Ed, 2019, 13(6):488-491.
|
[14] |
陈丽丹, 潘延凤. 血糖水平与肝衰竭患者预后的临床分析[J]. 中国实用医刊, 2017, 44(13):43-44.
|
|
Chen LD, Pan YF. Clinical analysis of blood glucose levels on the prognosis of liver failure[J]. Chin J Pract Med, 2017, 44(13):43-44.
|
[15] |
邓丽红, 潘兴飞, 李刚. 重症肝炎患者的血糖水平高低与预后的关系[J]. 胃肠病学和肝病学杂志, 2013, 22(8):794-796.
|
|
Deng LH, Pan XF, Li G. The relationship between blood glucose levels and the prognosis of severe hepatitis patients[J]. Chin J Gastroenterol Hepatol, 2013, 22(8):794-796.
|
[16] |
康文娟, 吴静, 武聚山, 等. 沉默信息调节因子6对慢加急性肝衰竭糖异生的影响和机制探讨[J]. 中华肝胆外科杂志, 2020, 26(3):165-169.
|
|
Kang WJ, Wu J, Wu JS, et al. Effect and mechanism of silent information regulator 6 on gluconeogenesis in chronic-on-acute liver failure[J]. Chin J Hepatobiliary Surg, 2020, 26(3):165-169.
|
[17] |
胡晗. 重症化慢性HBV感染者肝源性糖尿病的临床特点及与预后的相关性分析[D]. 遵义:遵义医科大学, 2021.
|
|
Hu H. Hepatogenous diabetes and its association with prognosis in patients with acute exacerbation of chronic HBV infection[D]. Zunyi:Zunyi Medcial University, 2021.
|
[18] |
张明霞, 李娟, 熊颖超, 等. 住院糖尿病病人发生无症状低血糖的相关因素分析[J]. 护理研究, 2017, 31(29):3695-3698.
|
|
Zhang MX, Li J, Xiong YC, et al. Analysis of correlation factors of asymptomatic hypoglycemia in hospitalized diabetic patients[J]. Nurs Res China, 2017, 31(29):3695-3698.
|
[19] |
Nanchal R, Subramanian R, Karvellas CJ, et al. Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU:cardiovascular,endocrine,hematologic,pul-monary and renal considerations:executive summary[J]. Crit Care Med, 2020, 48(3):415-419.
DOI
PMID
|
[20] |
Haraguchi M, Miyaaki H, Ichikawa T, et al. Glucose fluctuations reduce quality of sleep and of life in patients with liver cirrhosis[J]. Hepatol Int, 2017, 11(1):125-131.
DOI
PMID
|
[21] |
庞永丽, 方蘅英, 罗媛容, 等. 肝硬化患者营养评估与管理的最佳证据总结[J]. 中华护理杂志, 2020, 55(9):1420-1425.
|
|
Pang YL, Fang HY, Luo YR, et al. Best evidence summary of nutritional assessment and management in patients with liver cirrhosis[J]. Chin J Nurs, 2020, 55(9):1420-1425.
|
[22] |
乐华文, 王依屹. 凝血、纤溶和抗凝指标在慢性乙型肝炎病情进展中的变化规律[J]. 检验医学与临床, 2020, 17(6):755-757.
|
|
Yue HW, Wang YY. Change rule of blood coagulation,fibrinolysis and anti-coagulation indexes during the progress of chronic hepatitis B[J]. Lab Med Clin, 2020, 17(6):755-757.
|
[23] |
邵雪飞, 盛晓燕, 聂建军, 等. HBV感染对肝泡型包虫病肝切除患者术后肝功能及糖脂代谢和胰岛β细胞功能的影响[J]. 中华医院感染学杂志, 2021, 31(17):2609-2613.
|
|
Shao XF, Sheng XY, Nie JJ, et al. Effect of HBV infection on postoperative liver function,glucose and lipid metabolism and islet β-cell function of hepatic alveolar echinococcosis pa-tients undergoing hepatectomy[J]. Chin J Nosocomiol, 2021, 31(17):2609-2613.
|
[24] |
Bar-Dayan Y, Wainstein J, Schorr L, et al. Hypoglycemia-simplifying the ways to predict an old problem in the general ward[J]. Eur J Intern Med, 2019, 60:13-17.
DOI
PMID
|
[25] |
莫石柯. 肝硬化合并糖尿病患者胰岛素抵抗与肝功能关系研究[J]. 中国实用医药, 2021, 16(11):105-107.
|
|
Mo SK. Relationship between insulin resistance and liver function in patients with cirrhosis and diabetes mellitus[J]. China Pract Med, 2021, 16(11):105-107.
|
[26] |
田凤美, 张笑燕, 陆亚琼, 等. 糖尿病住院患者高血糖管理流程的优化及效果评价[J]. 中华护理杂志, 2018, 53(3):305-309.
|
|
Tian FM, Zhang XY, Lu YQ, et al. Application of healthcare failure mode and effect analysis of hyperglycemic management in hospitalized diabetic patients[J]. Chin J Nurs, 2018, 53(3):305-309.
|
[27] |
杨存美, 马燕兰, 亢君, 等. 糖尿病住院患者低血糖发生时间段的调查及分析[J]. 中华护理杂志, 2015, 50(3):303-307.
|
|
Yang CM, Ma YL, Kang J, et al. The time distribution of hy-poglycemia in hospitalized patients with diabetes[J]. Chin J Nurs, 2015, 50(3):303-307.
|
[28] |
胡晗, 田彩云, 张国远, 等. 肝源性糖尿病发病机制的最新进展[J]. 临床肝胆病杂志, 2021, 37(2):429-432.
|
|
Hu H, Tian CY, Zhang GY, et al. Latest advances in the patho-genesis of hepatogenous diabetes[J]. J Clin Hepatol, 2021, 37(2):429-432.
|
[29] |
赵娟, 惠威, 窦爱华, 等. 肝硬化合并糖尿病患者发生低血糖症的临床分析[J]. 临床肝胆病杂志, 2020, 36(2):329-332.
|
|
Zhao J, Hui W, Dou AH, et al. A clinical analysis of hypoglycemia in patients with liver cirrhosis and diabetes mellitus[J]. J Clin Hepatol, 2020, 36(2):329-332.
|